Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National Randomized Placebo-controlled Double-blind Multicenter Trial of LT4/LT3 Combination Therapy in Patients with Autoimmune Hypothyroidism: the T3-4-Hypo Trial.

NCT05682482 is registered in ClinicalTrials.gov with M. Medici as lead sponsor.

NCT NCT05682482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05682482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National Randomized Placebo-controlled Double-blind Multicenter Trial of LT4/LT3 Combination Therapy in Patients with Autoimmune Hypothyroidism: the T3-4-Hypo Trial.
Lead sponsor
M. Medici
Phase
Phase 3
Overall status
Recruiting
Start date
October 7, 2022
Completion date
January 31, 2028
Enrollment
600 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hypothyroidism